Alkermes Plc
NASDAQ:ALKS
Alkermes Plc
NASDAQ:ALKS
Price:
23.86 USD
-0.62%
Market Closed
Updated:
May 3, 2024
Alkermes Plc
Cash from Operating Activities
|
Alkermes Plc
Cash from Operating Activities Peer Comparison
Comparables:
AMRN
PRTA
M
MURA
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Alkermes Plc
NASDAQ:ALKS
|
Cash from Operating Activities
$401.4m
|
CAGR 3-Years
69%
|
CAGR 5-Years
32%
|
CAGR 10-Years
11%
|
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Cash from Operating Activities
$6.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Prothena Corporation PLC
NASDAQ:PRTA
|
Cash from Operating Activities
-$133.9m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
-15%
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Cash from Operating Activities
-$194.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Alkermes Plc's Cash from Operating Activities?
Cash from Operating Activities
401.4m
USD
401.4m
USD
Based on the financial report for Dec 31, 2023, Alkermes Plc's Cash from Operating Activities amounts to 401.4m USD.
What is Alkermes Plc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
11%
11%
Over the last year, the Cash from Operating Activities growth was 1 811%. The average annual Cash from Operating Activities growth rates for Alkermes Plc have been 69% over the past three years , 32% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet
